MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy - Sledge, G W, jr.; Toi, M; Neven, P (J Clin Oncol, 2017)